Skip to main content

Advertisement

Log in

The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

Sexual health problems and anxiety are disruptive symptoms in breast cancer survivors; however, little is known about these symptoms in postmenopausal breast cancer survivors on aromatase inhibitors therapies. This study aimed to determine the relationship between anxiety and vaginal-related sexual health problems in this population.

Methods

We analyzed cross-sectional data from a cohort study of postmenopausal women breast cancer survivors receiving aromatase inhibitors. Vaginal-related sexual health problems were assessed with the Breast Cancer Prevention Trial Symptom Checklist. Anxiety was assessed with the anxiety subscale of the Hospital Anxiety and Depression Scale. We used multivariable logistic regression to evaluate relationship between anxiety and vaginal-related sexual health adjusted for clinical and sociodemographic variables.

Results

Among 974 patients, 305 (31.3%) reported anxiety and 403 (41.4%) had vaginal-related sexual health problems. Compared to those without anxiety, patients with borderline and clinically abnormal anxiety reported higher rates of vaginal-related sexual health problems (36.8% vs. 49% and 55.7% respectively, p < 0.001). In multivariate analyses adjusted for clinical and sociodemographic factors, abnormal anxiety was associated with a higher rate of vaginal-related sexual health problems, with adjusted odds ratios of 1.69 (95% CI 1.06–2.70, p = 0.03). Vaginal-related sexual health problems were more frequent among patients who were under 65 years of age, received Taxane-based chemotherapy, reported depression, and were married/living with a partner (p < 0.05).

Conclusion

Among postmenopausal breast cancer survivors on aromatase inhibitors therapies, anxiety was significantly associated with vaginal-related sexual health problems. As treatments for sexual health problems are limited, results suggest that psychosocial interventions for anxiety could potentially be adapted to simultaneously address sexual health needs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data availability

The data of this study will be available from the corresponding author upon reasonable request.

Abbreviations

ACC:

Abramson Cancer Center

AI:

Aromatase inhibitor

AOR:

Adjusted odds ratio

BCPT:

Breast Cancer Prevention Trial Symptom Checklist

BMI:

Body mass index

95% CI:

95% Confidence interval

HADS:

Hospital Anxiety and Depression Scale

WABC:

Wellness After Breast Cancer

References

  1. Goldfarb S, Dickler M, Patil S et al (2011) Sexual dysfunction in women with breast cancer: prevalence and severity. J Sex Med 8:66–66

    Google Scholar 

  2. Mols F, Vingerhoets AJ, Coebergh JW, van de Poll-Franse LV (2005) Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41(17):2613–2619

    Article  PubMed  Google Scholar 

  3. Flynn KE, Jeffery DD, Keefe FJ et al (2011) Sexual functioning along the cancer continuum: Focus group results from the Patient-Reported Outcomes Measurement Information System (PROMIS®). Psycho-Oncol 20(4):378–386

    Article  Google Scholar 

  4. Bartula I, Sherman KA (2013) Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations. Breast Cancer Res Treat 141(2):173–185. https://doi.org/10.1007/s10549-013-2685-9

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ganz PA, Greendale GA, Petersen L, Zibecchi L, Kahn B, Belin TR (2000) Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. J Natl Cancer Inst 92(13):1054–1064. https://doi.org/10.1093/jnci/92.13.1054

    Article  CAS  PubMed  Google Scholar 

  6. Carreira H, Williams R, Funston G, Stanway S, Bhaskaran K (2021) Associations between breast cancer survivorship and adverse mental health outcomes: a matched population-based cohort study in the United Kingdom. PLoS Med 18(1):e1003504. https://doi.org/10.1371/journal.pmed.1003504

    Article  PubMed  PubMed Central  Google Scholar 

  7. Gilbert E, Ussher JM, Perz J (2010) Sexuality after breast cancer: a review. Maturitas 66(4):397–407. https://doi.org/10.1016/j.maturitas.2010.03.027

    Article  PubMed  Google Scholar 

  8. Ganz PA, Desmond KA, Belin TR, Meyerowitz BE, Rowland JH (1999) Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol 17(8):2371–2380. https://doi.org/10.1200/JCO.1999.17.8.2371

    Article  CAS  PubMed  Google Scholar 

  9. Burstein HJ, Lacchetti C, Anderson H et al (2018) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 37(5):423–438

    Article  PubMed  Google Scholar 

  10. Burwell SR, Case LD, Kaelin C, Avis NE (2006) Sexual problems in younger women after breast cancer surgery. J Clin Oncol 24(18):2815–2821

    Article  PubMed  Google Scholar 

  11. Seav SM, Dominick SA, Stepanyuk B et al (2015) Management of sexual dysfunction in breast cancer survivors: a systematic review. Women’s Midlife Health 1(1):9. https://doi.org/10.1186/s40695-015-0009-4

    Article  PubMed  PubMed Central  Google Scholar 

  12. Fobair P, Spiegel D (2009) Concerns about sexuality after breast cancer. Cancer J 15(1):19–26

    Article  PubMed  Google Scholar 

  13. Götze H, Friedrich M, Taubenheim S, Dietz A, Lordick F, Mehnert A (2020) Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support Care Cancer 28(1):211–220. https://doi.org/10.1007/s00520-019-04805-1

    Article  PubMed  Google Scholar 

  14. Kornblith AB, Ligibel J (2003) Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol 30(6):799–813. https://doi.org/10.1053/j.seminoncol.2003.08.025

    Article  PubMed  Google Scholar 

  15. Alagizy HASM, Soliman SS, Hegazy NN, Gohar SF (2020) Anxiety, depression and perceived stress among breast cancer patients: single institute experience. Middle East Curr Psychiatry 27(1):1–10

    Article  Google Scholar 

  16. Araujo RVFA, Nery IS, Andrade EMLR, Nogueira LT, Azevedo FHC (2019) Meditation effect on psychological stress level in women with breast cancer: a systematic review. Rev Esc Enferm USP. https://doi.org/10.1590/S1980-220X2018031303529

    Article  PubMed  Google Scholar 

  17. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A (2005) Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ 330(7493):702. https://doi.org/10.1136/bmj.38343.670868.D3

    Article  PubMed  PubMed Central  Google Scholar 

  18. Cvetkovic J, Nenadovic M (2016) Depression in breast cancer patients. Psychiatry Res 240:343–347. https://doi.org/10.1016/j.psychres.2016.04.048

    Article  PubMed  Google Scholar 

  19. Pumo V, Milone G, Iacono M et al (2012) Psychological and sexual disorders in long-term breast cancer survivors. Cancer Manag Res 4:61–65. https://doi.org/10.2147/cmar.S28547

    Article  PubMed  PubMed Central  Google Scholar 

  20. Fobair P, Stewart SL, Chang S, D’Onofrio C, Banks PJ, Bloom JR (2006) Body image and sexual problems in young women with breast cancer. Psycho-Oncol 15(7):579–594. https://doi.org/10.1002/pon.991

    Article  Google Scholar 

  21. Mao JJ, Su HI, Feng R et al (2011) Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivors. Breast Cancer Res 13(1):R8. https://doi.org/10.1186/bcr2813

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Stanton AL, Bernaards CA, Ganz PA (2005) The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97(6):448–456. https://doi.org/10.1093/jnci/dji069

    Article  PubMed  Google Scholar 

  23. Centers for Disease Control and Prevention (2022) Common sexual health problems and who can help. Secondary common sexual health problems and who can help. https://www.cdc.gov/cancer/survivors/healthy-living-guides/sexual-health/common-problems.htm

  24. Snaith RP (2003) The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes 1:29. https://doi.org/10.1186/1477-7525-1-29

    Article  PubMed  PubMed Central  Google Scholar 

  25. Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52(2):69–77. https://doi.org/10.1016/s0022-3999(01)00296-3

    Article  PubMed  Google Scholar 

  26. Carroll BT, Kathol RG, Noyes R, Wald TG, Clamon GH (1993) Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 15(2):69–74. https://doi.org/10.1016/0163-8343(93)90099-A

    Article  CAS  PubMed  Google Scholar 

  27. Smith AB, Selby PJ, Velikova G et al (2002) Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother Theory Res Pract 75(2):165–176. https://doi.org/10.1348/147608302169625

    Article  Google Scholar 

  28. da Costa FA, Ribeiro MC, Braga S et al (2016) Sexual dysfunction in breast cancer survivors: cross-cultural adaptation of the sexual activity questionnaire for use in Portugal. Acta Med Port 29(9):533–541. https://doi.org/10.20344/amp.7389

    Article  PubMed  Google Scholar 

  29. Raggio GA, Butryn ML, Arigo D, Mikorski R, Palmer SC (2014) Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health 29(6):632–650. https://doi.org/10.1080/08870446.2013.879136

    Article  PubMed  PubMed Central  Google Scholar 

  30. Runowicz CD, Leach CR, Henry NL et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin 66(1):43–73. https://doi.org/10.3322/caac.21319

    Article  PubMed  Google Scholar 

  31. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P (2002) Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 20:3137–3148

    Article  CAS  PubMed  Google Scholar 

  32. Baqutayan SM (2012) The effect of anxiety on breast cancer patients. Indian J Psychol Med 34(2):119–123. https://doi.org/10.4103/0253-7176.101774

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kaplan HS (1998) Anxiety and sexual dysfunction. J Clin Psychiatry 49:21–25

    Google Scholar 

  34. Tsaras K, Papathanasiou IV, Mitsi D et al (2018) Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev 19(6):1661–1669. https://doi.org/10.22034/APJCP.2018.19.6.1661

    Article  PubMed  PubMed Central  Google Scholar 

  35. Vaziri S, Lotfi KF (2010) Sexuality after breast cancer: need for guideline. Iran J Cancer Prev 5(1):10–15

    Google Scholar 

  36. Smedsland SK, Vandraas KF, Bohn SK et al (2022) Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey. Breast Cancer Res Treat 193(1):139–149. https://doi.org/10.1007/s10549-022-06544-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Ports KA, Barnack-Tavlaris JL, Syme ML, Perera RA, Lafata JE (2014) Sexual health discussions with older adult patients during periodic health exams. J Sex Med 11(4):901–908. https://doi.org/10.1111/jsm.12448

    Article  PubMed  PubMed Central  Google Scholar 

  38. Syme ML, Cohn TJ (2016) Examining aging sexual stigma attitudes among adults by gender, age, and generational status. Aging Ment Health 20(1):36–45. https://doi.org/10.1080/13607863.2015.1012044

    Article  PubMed  Google Scholar 

  39. Gibson LJ, Dawson C, Lawrence DH, Bliss JM (2007) Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Database Syst Rev 24(1):CD003370. https://doi.org/10.1002/14651858.CD003370.pub2

    Article  Google Scholar 

  40. Hong S, Didwania A, Olopade O, Ganschow P (2009) The expanding use of third-generation aromatase inhibitors: what the general internist needs to know. J Gen Intern Med 24(Suppl 2):S383–S388. https://doi.org/10.1007/s11606-009-1037-2

    Article  PubMed  Google Scholar 

  41. Taylor A, Gosney MA (2011) Sexuality in older age: essential considerations for healthcare professionals. Age Ageing 40(5):538–543. https://doi.org/10.1093/ageing/afr049

    Article  PubMed  Google Scholar 

  42. Waite LJ, Laumann EO, Das A, Schumm LP (2009) Sexuality: measures of partnerships, practices, attitudes, and problems in the National Social Life, Health, and Aging Study. J Gerontol B Psychol Sci Soc Sci 64(Suppl 1):i56–i66. https://doi.org/10.1093/geronb/gbp038

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported in part by a National Institutes of Health/National Cancer Institute (NCI) R01CA158243 (PI: Mao), NCI R01 CA240417 (PI: Mao), and NCI Cancer Center grant (P30 CA008748).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: JJM and KB. Methodology: JJM and KB. Formal analysis: SQL. Writing—original draft: KB. Writing—review and editing: KB, SC, XTL, and JJM. Supervision: JJM.

Corresponding author

Correspondence to Jun J. Mao.

Ethics declarations

Conflict of interest

The authors declare the following financial relationships: JJM reports grants received on behalf of Memorial Sloan Kettering Cancer Center from Tibet CheeZheng Tibetan Medicine Co. Ltd. and from Zhongke Health International LLC outside the submitted work. Other authors have no relevant financial or non-financial interests to disclose.

Ethics approval

This research was reviewed and approved by the Institutional Review Board of the University of Pennsylvania and the ACC Clinical Trials Scientific Review and Monitoring Committee.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent to publish

The authors affirm that human research participants provided informed consent for publication.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bryl, K., Chimonas, S., Li, X. et al. The relationship between anxiety and vaginal-related sexual health in postmenopausal breast cancer survivors on aromatase inhibitors therapies: a cross sectional study. Breast Cancer Res Treat 200, 257–264 (2023). https://doi.org/10.1007/s10549-023-06981-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-023-06981-5

Keywords

Navigation